263 related articles for article (PubMed ID: 34211042)
1. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring.
Bayaa R; Ndiaye MDB; Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Nasrin R; Ranaivomanana P; Raherinandrasana AH; Rakotonirina J; Rasolofo V; Delogu G; De Maio F; Goletti D; Endtz H; Ader F; Hamze M; Ismail MB; Pouzol S; Rakotosamimanana N; Hoffmann J;
Sci Rep; 2021 Jul; 11(1):13646. PubMed ID: 34211042
[TBL] [Abstract][Full Text] [Related]
2. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
3. Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.
Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Russomando G; Acosta CCD; Arenas R; Ranaivomanana PP; Razafimahatratra C; Herindrainy P; Rakotonirina J; Raherinandrasana AH; Rakotosamimanana N; Hamze M; Ismail MB; Bayaa R; Berland JL; De Maio F; Delogu G; Endtz H; Ader F; Goletti D; Hoffmann J
Front Immunol; 2020; 11():616450. PubMed ID: 33603746
[TBL] [Abstract][Full Text] [Related]
4. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.
Warsinske H; Vashisht R; Khatri P
PLoS Med; 2019 Apr; 16(4):e1002786. PubMed ID: 31013272
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
[TBL] [Abstract][Full Text] [Related]
6. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Penn-Nicholson A; Mbandi SK; Thompson E; Mendelsohn SC; Suliman S; Chegou NN; Malherbe ST; Darboe F; Erasmus M; Hanekom WA; Bilek N; Fisher M; Kaufmann SHE; Winter J; Murphy M; Wood R; Morrow C; Van Rhijn I; Moody B; Murray M; Andrade BB; Sterling TR; Sutherland J; Naidoo K; Padayatchi N; Walzl G; Hatherill M; Zak D; Scriba TJ; ; ; ; ; ; ; ;
Sci Rep; 2020 May; 10(1):8629. PubMed ID: 32451443
[TBL] [Abstract][Full Text] [Related]
7. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
[TBL] [Abstract][Full Text] [Related]
8. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
10. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
[TBL] [Abstract][Full Text] [Related]
11. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
13. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
[TBL] [Abstract][Full Text] [Related]
14. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
15. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India.
Leong S; Zhao Y; Joseph NM; Hochberg NS; Sarkar S; Pleskunas J; Hom D; Lakshminarayanan S; Horsburgh CR; Roy G; Ellner JJ; Johnson WE; Salgame P
Tuberculosis (Edinb); 2018 Mar; 109():41-51. PubMed ID: 29559120
[TBL] [Abstract][Full Text] [Related]
16. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children.
Buonsenso D; Delogu G; Perricone C; Grossi R; Careddu A; De Maio F; Palucci I; Sanguinetti M; Valentini P; Sali M
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229602
[TBL] [Abstract][Full Text] [Related]
18. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB.
Li Z; Hu J; Liu P; Cui D; Di H; Wu S
Sci Rep; 2021 Jul; 11(1):14516. PubMed ID: 34267288
[TBL] [Abstract][Full Text] [Related]
20. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
